Incidence, treatment and relative survival of early-onset colorectal cancer in the Netherlands since 1989

Previous studies showed that the incidence of early-onset colorectal cancer (EO-CRC, diagnosis

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European journal of cancer (1990) 2022-05, Vol.166, p.134-144
Hauptverfasser: Swartjes, Hidde, Brouwer, Nelleke P.M., de Nes, Lindsey C.F., van Erning, Felice N., Verhoeven, Rob H.A., Vissers, Pauline A.J., de Wilt, Johannes H.W.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 144
container_issue
container_start_page 134
container_title European journal of cancer (1990)
container_volume 166
creator Swartjes, Hidde
Brouwer, Nelleke P.M.
de Nes, Lindsey C.F.
van Erning, Felice N.
Verhoeven, Rob H.A.
Vissers, Pauline A.J.
de Wilt, Johannes H.W.
description Previous studies showed that the incidence of early-onset colorectal cancer (EO-CRC, diagnosis
doi_str_mv 10.1016/j.ejca.2022.01.029
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2640047107</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0959804922000624</els_id><sourcerecordid>2669598014</sourcerecordid><originalsourceid>FETCH-LOGICAL-c428t-ea630eaaf1dbedebaddecb95620743ed315429e1db9747e7e60eb641c2acefea3</originalsourceid><addsrcrecordid>eNp9kUtP3TAQhS1EBRfaP8CissSmC5KOHedhiQ1C5SGhdgNry7EnwlFuTG3nSvx7HF3aBQs2M4vzzdHoHELOGJQMWPNzLHE0uuTAeQmsBC4PyIZ1rSygq_kh2YCsZdGBkMfkJMYRANpOwBE5rmouQTKxIe5-Ns7ibPCCpoA6bXFOVM-WBpx0cjukcQk7t9MT9QNFHabXws8REzV-8gFNyorR2SBQN9P0jPQ35hmmbBJpdFmhTHbyK_ky6Cnit_d9Sp5ufj1e3xUPf27vr68eCiN4lwrUTQWo9cBsjxZ7bS2aXtYNh1ZUaCtWCy4xq7IVLbbYAPaNYIZrgwPq6pT82Pu-BP93wZjU1kWDU_4H_RIVbwSAaBm0GT3_gI5-CXP-LlNNDq8DJjLF95QJPsaAg3oJbqvDq2Kg1iLUqNYi1FqEAqZyEfno-7v10m_R_j_5l3wGLvcA5ix2DoOKxq09WLeGqqx3n_m_Af2_mpw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2669598014</pqid></control><display><type>article</type><title>Incidence, treatment and relative survival of early-onset colorectal cancer in the Netherlands since 1989</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Swartjes, Hidde ; Brouwer, Nelleke P.M. ; de Nes, Lindsey C.F. ; van Erning, Felice N. ; Verhoeven, Rob H.A. ; Vissers, Pauline A.J. ; de Wilt, Johannes H.W.</creator><creatorcontrib>Swartjes, Hidde ; Brouwer, Nelleke P.M. ; de Nes, Lindsey C.F. ; van Erning, Felice N. ; Verhoeven, Rob H.A. ; Vissers, Pauline A.J. ; de Wilt, Johannes H.W.</creatorcontrib><description>Previous studies showed that the incidence of early-onset colorectal cancer (EO-CRC, diagnosis &lt;50 years) is rising in Western countries. Additionally, young patients present with more advanced disease. Integrated nationwide assessment of epidemiologically and clinically relevant trends would provide more insight into this specific group of patients with CRC. We aimed to provide an analysis of trends in age- and stage-specific incidence, characteristics, treatment and relative survival of patients with EO-CRC in the Netherlands and compare these with 50- to 59-year-old patients. Data from 1989 to 2018 were retrieved from the Netherlands Cancer Registry. Non-standardised age-specific incidence rates were calculated, and trends were assessed using Joinpoint regression. Treatment and 5-year relative survival trends were provided and compared between EO-CRC and 50- to 59-year-old patients. The EO-CRC incidence annually increased with 0.7–2.1% over the last decades. CRC incidence for the 50- to 59-year-old population annually increased with 0.8–1.7% until 2006 and showed a major increase in incidence after the introduction of nationwide screening in 2014. Stage III and Stage IV CRC primarily increased across the studied age groups, while Stage I and Stage II CRC did not. Patients with EO-CRC received multimodal treatment more often than 50- to 59-year-old patients, but differences were minor. Relative survival increased over time and showed little differences between EO-CRC and 50- to 59-year-old patients. Only few epidemiological and clinical differences were found between EO-CRC and 50- to 59-year-old patients; hence, the urge for a specific approach of EO-CRC in screening and treatment guidelines might be tempered. •Early-onset colorectal cancer (EO-CRC) incidence increased in the Netherlands with 0.7–2.1% over the last decades.•This increase in incidence was highly comparable to the 50- to 59-year-old population.•EO-CRC treatment and relative survival differed slightly from 50- to 59-year-old patients with CRC.•The urge for a specific approach of EO-CRC in guidelines might be tempered.</description><identifier>ISSN: 0959-8049</identifier><identifier>EISSN: 1879-0852</identifier><identifier>DOI: 10.1016/j.ejca.2022.01.029</identifier><identifier>PMID: 35290914</identifier><language>eng</language><publisher>England: Elsevier Ltd</publisher><subject>Age ; Age of onset ; Cancer ; Colorectal cancer ; Colorectal carcinoma ; Colorectal neoplasms ; Colorectal Neoplasms - diagnosis ; Colorectal Neoplasms - epidemiology ; Colorectal Neoplasms - therapy ; Epidemiology ; Health services ; Humans ; Incidence ; Mass Screening ; Middle Aged ; Netherlands - epidemiology ; Patients ; Registries ; Survival ; Survival analysis ; Therapy ; Trends</subject><ispartof>European journal of cancer (1990), 2022-05, Vol.166, p.134-144</ispartof><rights>2022 The Author(s)</rights><rights>Copyright © 2022 The Author(s). Published by Elsevier Ltd.. All rights reserved.</rights><rights>Copyright Elsevier Science Ltd. May 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c428t-ea630eaaf1dbedebaddecb95620743ed315429e1db9747e7e60eb641c2acefea3</citedby><cites>FETCH-LOGICAL-c428t-ea630eaaf1dbedebaddecb95620743ed315429e1db9747e7e60eb641c2acefea3</cites><orcidid>0000-0001-7349-2032 ; 0000-0002-0677-888X ; 0000-0001-9678-1611</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.ejca.2022.01.029$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35290914$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Swartjes, Hidde</creatorcontrib><creatorcontrib>Brouwer, Nelleke P.M.</creatorcontrib><creatorcontrib>de Nes, Lindsey C.F.</creatorcontrib><creatorcontrib>van Erning, Felice N.</creatorcontrib><creatorcontrib>Verhoeven, Rob H.A.</creatorcontrib><creatorcontrib>Vissers, Pauline A.J.</creatorcontrib><creatorcontrib>de Wilt, Johannes H.W.</creatorcontrib><title>Incidence, treatment and relative survival of early-onset colorectal cancer in the Netherlands since 1989</title><title>European journal of cancer (1990)</title><addtitle>Eur J Cancer</addtitle><description>Previous studies showed that the incidence of early-onset colorectal cancer (EO-CRC, diagnosis &lt;50 years) is rising in Western countries. Additionally, young patients present with more advanced disease. Integrated nationwide assessment of epidemiologically and clinically relevant trends would provide more insight into this specific group of patients with CRC. We aimed to provide an analysis of trends in age- and stage-specific incidence, characteristics, treatment and relative survival of patients with EO-CRC in the Netherlands and compare these with 50- to 59-year-old patients. Data from 1989 to 2018 were retrieved from the Netherlands Cancer Registry. Non-standardised age-specific incidence rates were calculated, and trends were assessed using Joinpoint regression. Treatment and 5-year relative survival trends were provided and compared between EO-CRC and 50- to 59-year-old patients. The EO-CRC incidence annually increased with 0.7–2.1% over the last decades. CRC incidence for the 50- to 59-year-old population annually increased with 0.8–1.7% until 2006 and showed a major increase in incidence after the introduction of nationwide screening in 2014. Stage III and Stage IV CRC primarily increased across the studied age groups, while Stage I and Stage II CRC did not. Patients with EO-CRC received multimodal treatment more often than 50- to 59-year-old patients, but differences were minor. Relative survival increased over time and showed little differences between EO-CRC and 50- to 59-year-old patients. Only few epidemiological and clinical differences were found between EO-CRC and 50- to 59-year-old patients; hence, the urge for a specific approach of EO-CRC in screening and treatment guidelines might be tempered. •Early-onset colorectal cancer (EO-CRC) incidence increased in the Netherlands with 0.7–2.1% over the last decades.•This increase in incidence was highly comparable to the 50- to 59-year-old population.•EO-CRC treatment and relative survival differed slightly from 50- to 59-year-old patients with CRC.•The urge for a specific approach of EO-CRC in guidelines might be tempered.</description><subject>Age</subject><subject>Age of onset</subject><subject>Cancer</subject><subject>Colorectal cancer</subject><subject>Colorectal carcinoma</subject><subject>Colorectal neoplasms</subject><subject>Colorectal Neoplasms - diagnosis</subject><subject>Colorectal Neoplasms - epidemiology</subject><subject>Colorectal Neoplasms - therapy</subject><subject>Epidemiology</subject><subject>Health services</subject><subject>Humans</subject><subject>Incidence</subject><subject>Mass Screening</subject><subject>Middle Aged</subject><subject>Netherlands - epidemiology</subject><subject>Patients</subject><subject>Registries</subject><subject>Survival</subject><subject>Survival analysis</subject><subject>Therapy</subject><subject>Trends</subject><issn>0959-8049</issn><issn>1879-0852</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kUtP3TAQhS1EBRfaP8CissSmC5KOHedhiQ1C5SGhdgNry7EnwlFuTG3nSvx7HF3aBQs2M4vzzdHoHELOGJQMWPNzLHE0uuTAeQmsBC4PyIZ1rSygq_kh2YCsZdGBkMfkJMYRANpOwBE5rmouQTKxIe5-Ns7ibPCCpoA6bXFOVM-WBpx0cjukcQk7t9MT9QNFHabXws8REzV-8gFNyorR2SBQN9P0jPQ35hmmbBJpdFmhTHbyK_ky6Cnit_d9Sp5ufj1e3xUPf27vr68eCiN4lwrUTQWo9cBsjxZ7bS2aXtYNh1ZUaCtWCy4xq7IVLbbYAPaNYIZrgwPq6pT82Pu-BP93wZjU1kWDU_4H_RIVbwSAaBm0GT3_gI5-CXP-LlNNDq8DJjLF95QJPsaAg3oJbqvDq2Kg1iLUqNYi1FqEAqZyEfno-7v10m_R_j_5l3wGLvcA5ix2DoOKxq09WLeGqqx3n_m_Af2_mpw</recordid><startdate>202205</startdate><enddate>202205</enddate><creator>Swartjes, Hidde</creator><creator>Brouwer, Nelleke P.M.</creator><creator>de Nes, Lindsey C.F.</creator><creator>van Erning, Felice N.</creator><creator>Verhoeven, Rob H.A.</creator><creator>Vissers, Pauline A.J.</creator><creator>de Wilt, Johannes H.W.</creator><general>Elsevier Ltd</general><general>Elsevier Science Ltd</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-7349-2032</orcidid><orcidid>https://orcid.org/0000-0002-0677-888X</orcidid><orcidid>https://orcid.org/0000-0001-9678-1611</orcidid></search><sort><creationdate>202205</creationdate><title>Incidence, treatment and relative survival of early-onset colorectal cancer in the Netherlands since 1989</title><author>Swartjes, Hidde ; Brouwer, Nelleke P.M. ; de Nes, Lindsey C.F. ; van Erning, Felice N. ; Verhoeven, Rob H.A. ; Vissers, Pauline A.J. ; de Wilt, Johannes H.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c428t-ea630eaaf1dbedebaddecb95620743ed315429e1db9747e7e60eb641c2acefea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Age</topic><topic>Age of onset</topic><topic>Cancer</topic><topic>Colorectal cancer</topic><topic>Colorectal carcinoma</topic><topic>Colorectal neoplasms</topic><topic>Colorectal Neoplasms - diagnosis</topic><topic>Colorectal Neoplasms - epidemiology</topic><topic>Colorectal Neoplasms - therapy</topic><topic>Epidemiology</topic><topic>Health services</topic><topic>Humans</topic><topic>Incidence</topic><topic>Mass Screening</topic><topic>Middle Aged</topic><topic>Netherlands - epidemiology</topic><topic>Patients</topic><topic>Registries</topic><topic>Survival</topic><topic>Survival analysis</topic><topic>Therapy</topic><topic>Trends</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Swartjes, Hidde</creatorcontrib><creatorcontrib>Brouwer, Nelleke P.M.</creatorcontrib><creatorcontrib>de Nes, Lindsey C.F.</creatorcontrib><creatorcontrib>van Erning, Felice N.</creatorcontrib><creatorcontrib>Verhoeven, Rob H.A.</creatorcontrib><creatorcontrib>Vissers, Pauline A.J.</creatorcontrib><creatorcontrib>de Wilt, Johannes H.W.</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of cancer (1990)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Swartjes, Hidde</au><au>Brouwer, Nelleke P.M.</au><au>de Nes, Lindsey C.F.</au><au>van Erning, Felice N.</au><au>Verhoeven, Rob H.A.</au><au>Vissers, Pauline A.J.</au><au>de Wilt, Johannes H.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Incidence, treatment and relative survival of early-onset colorectal cancer in the Netherlands since 1989</atitle><jtitle>European journal of cancer (1990)</jtitle><addtitle>Eur J Cancer</addtitle><date>2022-05</date><risdate>2022</risdate><volume>166</volume><spage>134</spage><epage>144</epage><pages>134-144</pages><issn>0959-8049</issn><eissn>1879-0852</eissn><abstract>Previous studies showed that the incidence of early-onset colorectal cancer (EO-CRC, diagnosis &lt;50 years) is rising in Western countries. Additionally, young patients present with more advanced disease. Integrated nationwide assessment of epidemiologically and clinically relevant trends would provide more insight into this specific group of patients with CRC. We aimed to provide an analysis of trends in age- and stage-specific incidence, characteristics, treatment and relative survival of patients with EO-CRC in the Netherlands and compare these with 50- to 59-year-old patients. Data from 1989 to 2018 were retrieved from the Netherlands Cancer Registry. Non-standardised age-specific incidence rates were calculated, and trends were assessed using Joinpoint regression. Treatment and 5-year relative survival trends were provided and compared between EO-CRC and 50- to 59-year-old patients. The EO-CRC incidence annually increased with 0.7–2.1% over the last decades. CRC incidence for the 50- to 59-year-old population annually increased with 0.8–1.7% until 2006 and showed a major increase in incidence after the introduction of nationwide screening in 2014. Stage III and Stage IV CRC primarily increased across the studied age groups, while Stage I and Stage II CRC did not. Patients with EO-CRC received multimodal treatment more often than 50- to 59-year-old patients, but differences were minor. Relative survival increased over time and showed little differences between EO-CRC and 50- to 59-year-old patients. Only few epidemiological and clinical differences were found between EO-CRC and 50- to 59-year-old patients; hence, the urge for a specific approach of EO-CRC in screening and treatment guidelines might be tempered. •Early-onset colorectal cancer (EO-CRC) incidence increased in the Netherlands with 0.7–2.1% over the last decades.•This increase in incidence was highly comparable to the 50- to 59-year-old population.•EO-CRC treatment and relative survival differed slightly from 50- to 59-year-old patients with CRC.•The urge for a specific approach of EO-CRC in guidelines might be tempered.</abstract><cop>England</cop><pub>Elsevier Ltd</pub><pmid>35290914</pmid><doi>10.1016/j.ejca.2022.01.029</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-7349-2032</orcidid><orcidid>https://orcid.org/0000-0002-0677-888X</orcidid><orcidid>https://orcid.org/0000-0001-9678-1611</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0959-8049
ispartof European journal of cancer (1990), 2022-05, Vol.166, p.134-144
issn 0959-8049
1879-0852
language eng
recordid cdi_proquest_miscellaneous_2640047107
source MEDLINE; Elsevier ScienceDirect Journals
subjects Age
Age of onset
Cancer
Colorectal cancer
Colorectal carcinoma
Colorectal neoplasms
Colorectal Neoplasms - diagnosis
Colorectal Neoplasms - epidemiology
Colorectal Neoplasms - therapy
Epidemiology
Health services
Humans
Incidence
Mass Screening
Middle Aged
Netherlands - epidemiology
Patients
Registries
Survival
Survival analysis
Therapy
Trends
title Incidence, treatment and relative survival of early-onset colorectal cancer in the Netherlands since 1989
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-17T12%3A14%3A06IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Incidence,%20treatment%20and%20relative%20survival%20of%20early-onset%20colorectal%20cancer%20in%20the%20Netherlands%20since%201989&rft.jtitle=European%20journal%20of%20cancer%20(1990)&rft.au=Swartjes,%20Hidde&rft.date=2022-05&rft.volume=166&rft.spage=134&rft.epage=144&rft.pages=134-144&rft.issn=0959-8049&rft.eissn=1879-0852&rft_id=info:doi/10.1016/j.ejca.2022.01.029&rft_dat=%3Cproquest_cross%3E2669598014%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2669598014&rft_id=info:pmid/35290914&rft_els_id=S0959804922000624&rfr_iscdi=true